Operating Room Usage of Vuzix Smart Glasses Continues to Expand Via Solution Providers Pixee Medical and Rods&Cones

Rhea-AI Summary

Vuzix Corporation (NASDAQ: VUZI) announced growing orders for its smart glasses from healthcare firms like Pixee Medical and Rods&Cones, indicating increased adoption in the operating room. Pixee Medical's Knee+ solution will launch in the US, enhancing AR capabilities for orthopedic surgeries. Rods&Cones reports usage in over 600 hospitals worldwide, emphasizing a shift toward remote technology. This expansion in healthcare applications positions Vuzix as a key player in transforming medical practices.

Positive

• Increasing orders from healthcare firms signify a growing market for smart glasses.
• Launch of Pixee Medical's Knee+ in the US enhances Vuzix's visibility in the orthopedic sector.
• Rods&Cones' adoption of Vuzix glasses in over 600 hospitals worldwide indicates significant market penetration.

Negative

• None.

-  Vuzix has been receiving ongoing smart glasses orders from these firms, as well as others within healthcare, as global awareness and adoption grows

ROCHESTER, N.Y., March 22, 2022 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that use of its smart glasses within the operating room, as well as for other healthcare use cases, continues to expand as partner firms such as Pixee Medical and Rods&Cones increase their rollout of Vuzix-powered solutions.

Yesterday, Pixee Medical announced that its Knee+ AR computer-assisted orthopedic solution will be commercially launched in the United States, providing a perfect fit for Ambulatory Surgical Centers (ASCs). Launched in Europe and Australia early in 2021, Pixee's solution will be formally launched in the US at the American Association of Orthopaedic Surgeons (AAOS) Annual Meeting on March 22-26 in Chicago, where the company will meet with surgeons and finalize the organization of its distribution channel.

Additionally, Pixee Medical added that it will soon be adding new features to its Knee+ platform, with soft tissue balancing, kinematic alignment and data connectivity. It will also be expanding its portfolio with a mixed reality product for total shoulder arthroplasty and with an easy-to-use cup orientation and leg length controlling AR tool for total hip arthroplasty. Knee+ is also now compatible with surgical hoods.

Rods&Cones has been a growing consumer of Vuzix M400 smart glasses, which let staff in the operating room, ICU or other medical facility, including surgeons, instrumentalist nurses and other healthcare professionals, provide 4K broadcast quality imagery to others while interacting with patients and staff from a safe distance. To date, Rods&Cones is active in more than 600 hospitals across more than 30 countries and the company anticipates that 2022 will be the year when companies and medical providers start changing their models to prioritize remote technology at the heart of their operations.

Rods&Cones recently announced that its remote access service is compatible with the Pixee Knee+ augmented reality solution for total knee arthroplasty. The compatibility of the two solutions is expected to allow surgeons to use augmented reality during total knee arthroplasty surgeries, while also connecting remotely with other medical experts around the world.

"Firms like Pixee Medical and Rods&Cones are innovators within the healthcare sector and their solutions are facilitating communications and learning, reducing costs, and improving outcomes in operating rooms around the world with the help of Vuzix smart glasses," said Paul Travers, President and Chief Executive Officer at Vuzix. We look forward to working with these and other providers to help transform the healthcare industry in 2022 and beyond.

Learn more about Rods&Cones here: https://www.rods-cones.com/

Learn more about Pixee Medical here: https://www.pixee-medical.com/en/

About Vuzix Corporation

Vuzix is a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 245 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2022 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan.  For more information, visit the Vuzix website, Twitter and Facebook pages.

Forward-Looking Statements Disclaimer

Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward-looking statements contained in this release relate to Vuzix Smart Glasses, our business relationship and future opportunities with Pixee Medical and Rods&Cones, and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Vuzix Media and Investor Relations Contact:

Ed McGregor, Director of Investor Relations,
Vuzix Corporation
ed_mcgregor@vuzix.com  
Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com  www.vuzix.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/operating-room-usage-of-vuzix-smart-glasses-continues-to-expand-via-solution-providers-pixee-medical-and-rodscones-301508041.html

SOURCE Vuzix Corporation

FAQ

What recent developments has Vuzix Corporation made in the healthcare sector?

Vuzix has seen increased orders for its smart glasses from healthcare firms, notably with Pixee Medical launching its Knee+ AR solution in the US.

What is the significance of Rods&Cones using Vuzix smart glasses?

Rods&Cones' usage of Vuzix smart glasses in over 600 hospitals highlights the growing integration of AR technology in medical practices.

How is Vuzix Corporation impacting surgical procedures?

Vuzix smart glasses facilitate remote communication and enhanced visualization in surgeries, improving operational efficiency and outcomes.

When will Pixee Medical's Knee+ be launched in the US?

Pixee Medical's Knee+ AR solution is set to launch during the American Association of Orthopaedic Surgeons meeting from March 22-26, 2022.